6 results on '"Ariana Pereira"'
Search Results
2. Sa1436 IMPACT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME ON THE OUTCOMES AND SEVERITY OF ACUTE PANCREATITIS.
- Author
-
Garcia, Ariana Pereira, Garcia, Paulina Rodriguez, Calleros, Jorge Hernandez, Uscanga, Luis, and Luna, Mario Peláez
- Published
- 2024
- Full Text
- View/download PDF
3. Fatty acid-induced toxicity and neutral lipid accumulation in insulin-producing RINm5F cells
- Author
-
Azevedo-Martins, Anna Karenina, Monteiro, Ariana Pereira, Lima, Camila Lopes, Lenzen, Sigurd, and Curi, Rui
- Subjects
- *
FATTY acids , *INSULIN , *DNA , *LINOLEIC acid , *ESSENTIAL fatty acids - Abstract
Abstract: Fatty acids have been shown to cause death of rat and human primary pancreatic beta cells and of insulin-producing cell lines. These studies focused mainly on saturated and monounsaturated FA such as palmitic, stearic and oleic acids. In this study, we have performed a comparison of the toxicity of a wider range of FA. The toxicity of different FA to insulin-producing RINm5F cells was assessed by flow cytometry measuring loss of plasma membrane integrity and increase in DNA fragmentation. Additionally, the FA induced neutral lipid accumulation and the FA composition were determined. Palmitic, linoleic, γ-linolenic, oleic, stearic, and eicosapentaenoic acid caused DNA fragmentation of insulin-producing RINm5F cells. Loss of membrane integrity was mainly caused by linoleic and γ-linolenic acid. There was no correlation between cytotoxicity and the abundance of the FA in the cells as determined by HPLC analysis. Taken as whole, the toxic effect of the FA on insulin-producing RINm5F cells varied irrespective of the chain length and the degree of unsaturation. In these cells PA and LA exhibited the highest toxicity, whereas AA was not toxic. In addition, the toxicity of most tested FA was inversely related to low NLA, except for AA and EPA. The results of this study contribute to the understanding of the role of FA in the impairment of pancreatic beta cell function that occurs in type 2 diabetes and obesity. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
4. Biological and pharmacological aspects of tannins and potential biotechnological applications.
- Author
-
Melo, Luciana Fentanes Moura de, Aquino-Martins, Verônica Giuliani de Queiroz, Silva, Ariana Pereira da, Oliveira Rocha, Hugo Alexandre, and Scortecci, Katia Castanho
- Subjects
- *
TANNINS , *PHENOLS , *ALZHEIMER'S disease , *GUT microbiome , *METABOLITES , *WINE industry - Abstract
• Polyphenols have several applications, such as medical, environmental, and industrial. • Tannins can prevent conditions such as neurodegenerative diseases. • Polyphenols and tannins influence the gut microbiota. • Tannins have several biotechnological applications, such as removing contaminations. • Tannins have direct application in the wine industry. Secondary metabolites are divided into three classes: phenolic, terpenoid, and nitrogenous compounds. Phenolic compounds are also known as polyphenols and include tannins, classified as hydrolysable or condensed. Herein, we explored tannins for their ROS reduction characteristics and role in homeostasis. These activities are associated with the numbers and degree of polymerisation of reactive hydroxyl groups present in the phenolic rings of tannins. These characteristics are associated with anti-inflammatory, anti-aging, and anti-proliferative health benefits. Tannins can reduce the risk of cancer and neurodegenerative diseases, such as cardiovascular diseases and Alzheimer's, respectively. These biomolecules may be used as nutraceuticals to maintain good gut microbiota. Industrial applications include providing durability to leather, anti-corrosive properties to metals, and substrates for 3D printing and in bio-based foam manufacture. This review updates regarding tannin-based research and highlights its biological and pharmacological relevance and potential applications. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.
- Author
-
Arrieta, Oscar, Salas, Alejandro Avilés, Cardona, Andrés F., Díaz-García, Diego, Lara-Mejía, Luis, Escamilla, Ixel, García, Ariana Pereira, Pérez, Enrique Caballé, Raez, Luis E., Rolfo, Christian, and Rosell, Rafael
- Subjects
- *
BRAIN metastasis , *NEURAL development , *PROGNOSIS , *METASTASIS , *LUNGS - Abstract
• In the present study IASLC/ATS/ERS classification was useful to identify a high risk population of developing brain metastases in advanced lung adenocarcinoma. • The solid predominant histologic subtype consistently had a significantly higher probability of developing brain metastases even after adjusting by the histological grade and cofounding variables. • According to the histologic grade, moderately differentiated tumors had the highest risk of brain affection irrespective of the lung predominant adenocarcinoma subtype. • IASLC/ATS/ERS classification might suggest more aggressive clinical approaches and closer monitoring in patients with increased hazards for brain metastases development, integrating this classification for risk stratification. Brain metastases (BM) are frequent among lung cancer patients, affecting prognosis and quality of life. The International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS) and European Respiratory Society (ERS) lung adenocarcinoma (LADC) classification (IASLC/ATS/ERS) has prognostic impact in early-stage disease; however, its role in the advanced setting is not precise. This study aims to determine the correlation between the predominant histological subtype and the risk of developing brain metastases (BM) in locally advanced and metastatic (stages IIIB-IV) LADC. A total of 710 patients with LADC were treated at our institution from January 2010 to December 2017. After excluding patients with brain metastases at diagnoses (n = 151), they were categorized according to the IASLC/ATS/ERS LADC classification to estimate the risk of developing brain metastases. A competing risk analysis was employed, considering death a competing risk event. From 559 patients, the mean age was 59 ± 13.2 years, women (52.4 %), and clinical-stage IV (79.2 %). LADC subtypes distribution was lepidic (11.6 %), acinar (37.9 %), papillary (10.2 %), micropapillary (6.8 %), and solid (33.5 %). A total of 27.0 % of patients developed BM, 32.9 % died without brain affection, and 40.0 % did not progress. The predominantly solid subtype showed the greatest probability of all subtypes for developing BM [HR 4.0; 95 % CI (1.80−8.91), p = 0.0006], followed by micropapillary [HR1.11; 95 % CI (0.36−3.39), p = 0.85). The solid subtype, moderately differentiated tumors, age, and ECOG PS (>2) were associated with increased hazards in the multivariate analysis. According to the IASLC/ATS/ERS classification, the predominantly solid pattern was significantly associated with an increased risk of developing BM in patients with locally advanced and metastatic LADC. Its prognostic value might help explore novel clinical approaches, modify monitoring for earlier detection, prevent complications, and reduce morbidity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Selenium reduces bradykinesia and DNA damage in a rat model of Parkinson's disease.
- Author
-
Ellwanger, Joel Henrique, Molz, Patrícia, Dallemole, Danieli Rosane, dos Santos, Ariana Pereira, Müller, Talise Ellwanger, Cappelletti, Lucas, da Silva, Manoela Gonçalves, Rech Franke, Silvia Isabel, Prá, Daniel, and Pêgas Henriques, João Antonio
- Subjects
- *
DRUG therapy for Parkinson's disease , *SELENIUM , *DNA analysis , *ANALYSIS of variance , *ANIMAL experimentation , *DNA , *EXPERIMENTAL design , *HUMAN locomotion , *PROBABILITY theory , *RATS , *RESEARCH funding , *STATISTICS , *DATA analysis , *DATA analysis software , *DESCRIPTIVE statistics , *THERAPEUTICS - Abstract
Objective: The aim of this study was to explore the effects of selenium (Se) on locomotor activity and DNA damage in a rat model of Parkinson's disease (PD) induced by paraquat (PQ). Methods: Forty-eight male Wistar rats were divided into four groups: control group (n = 12), Se group (n = 12), PQ group (n = 12), and Se + PQ group (n = 12). PQ was administered intraperitoneally (10 mg/kg). Se was offered in the drinking water at a concentration of 11.18 mg/L. Locomotor activity was evaluated weekly using the narrow beam test. The comet assay was performed to assess the level of DNA damage in leukocytes and in brain cells. Results: As expected, increased DNA damage was found in the PQ group compared with the control and Se groups (P < 0.001). Interestingly, coadministration of Se and PQ effectively prevented the harmful effects of the toxin in locomotor activity and at the molecular level, reducing bradykinesia (P < 0.01) and DNA damage in leukocytes compared with the PQ-only group (P < 0.001), whereas the levels of DNA damage were comparable to those found in the control and Se groups (P > 0.05). Using the comet assay to analyze brain cells, no differences were found between the groups with regard to damage index (P = 0.774), damage frequency (P = 0.817), or non-detectable cell nuclei (P = 0.481). Conclusion: In this experimental model of PQ-induced PD, the use of Se could contribute to the maintenance of locomotor activity and the integrity of leukocytes DNA. No changes in the levels of DNA damage in brain cells were observed between the experimental groups. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.